Provider News & Updates – June 2023 June 2, 2023 End of Public Health Emergency Changes Medical Benefits The COVID-19 public health emergency officially ended on May 11, 2023. As a result, changes apply to some medical and pharmacy out-of-pocket costs for COVID-19-related services provided to Samaritan Advantage Health Plans, Samaritan Choice Plans and Samaritan Employer Group Plans members. Samaritan Advantage Health Plans benefit changes include the following: FDA-approved COVID-19 vaccines have a zero-dollar ($0) copay when prescribed by a health care professional and filled at a network pharmacy. Anti-viral prescriptions for Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) have a Tier 4 copay when prescribed by a health care professional and filled at a network pharmacy. COVID-19 diagnostic tests performed by a physician or laboratory are free and have no cost share. At home over-the-counter COVID-19 tests can be purchased by the member and reimbursed through the over-the-counter benefit. Samaritan Choice Plans and Samaritan Employer Group Plans benefit changes include the following: FDA-approved COVID-19 vaccines have a zero-dollar ($0) copay when prescribed by a health care professional and filled at a network pharmacy. Anti-viral prescriptions for Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) have a Tier 3 copay when prescribed by a health care professional and filled at a network pharmacy. COVID-19 diagnostic tests performed by a provider or laboratory are subject to plan deductible, copay and coinsurance. At-home over-the-counter COVID-19 tests are not covered. Contracted telehealth services continue to have a zero-dollar ($0) copay for all Samaritan Advantage Health Plans, Samaritan Choice Plans and Employer Group Plans members for the remainder of 2023. Non-contracted telehealth services will apply to members’ out-of-network plan benefits.